Gene · 175
Papers942
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 942
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose-6-Phosphorylation and Cellular Uptake of Aspartylglucosaminidase. | J Inherit Metab Dis | 2026 | 42676279 | PubTator, text mining | PubMed |
| Phase-Transformation-Driven Orientation Selection and Anisotropic Properties in Gallium Microfibers. | Small | 2026 | 42639720 | PubTator, text mining | PubMed |
| Biochemical characterization of aspartylglucosaminidase missense variants of unclear significance reveals different degrees of functional impairment. | Front Chem | 2026 | 42482697 | PubTator, text mining | PubMed |
| Analysis of end-stage renal disease mediated by cuproptosis-related genes. | Clin Nephrol | 2026 | 42383521 | PubTator, text mining | PubMed |
| Associations of systemic immune-inflammation index and aggregate index of systemic inflammation with acute gouty arthritis in men: a cross-sectional study. | Front Med (Lausanne) | 2026 | 42221133 | PubTator, text mining | PubMed |
| Clinical Utility of Anti-Gliadin IgG Antibody (AGA IgG) and Characterization of Patients with Suspected Non-Celiac Gluten Sensitivity: Prospective, Observational Study in Japan. | Nutrients | 2026 | 42197067 | PubTator, text mining | PubMed |
| Actionable Genomic Alterations and Survival in Gallbladder Cancer: A Documented Stage- and Treatment-Matched Real-World Global Analysis. | Cancers (Basel) | 2026 | 42122248 | PubTator, text mining | PubMed |
| Sex-specific genetic drivers of memory, executive functioning and language in older adults. | Brain | 2026 | 41989867 | PubTator, text mining | PubMed |
| Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. | Front Pharmacol | 2026 | 41769701 | PubTator, text mining | PubMed |
| Targeting tRNA-Arg-TCT-4-1 suppresses cancer cell growth and tumorigenesis. | bioRxiv | 2026 | 41757043 | PubTator, text mining | PubMed |
| Mass Screening Strategies for Celiac Disease in Apparently Healthy Children and Adolescents: A Systematic Review. | Medicina (Kaunas) | 2026 | 41752646 | PubTator, text mining | PubMed |
| Sustainable metal recovery from waste printed circuit boards through citric acid leaching using response surface methodology and predictive modelling. | RSC Adv | 2026 | 41726236 | PubTator, text mining | PubMed |
| Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model. | Int J Nanomedicine | 2026 | 41725888 | PubTator, text mining | PubMed |
| Trichoscopic Features, Clinical Correlates, and Risk Prediction in Female Pattern Hair Loss: A Retrospective Case-Control Study. | Clin Cosmet Investig Dermatol | 2026 | 41710524 | PubTator, text mining | PubMed |
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315). | Eur J Cancer | 2026 | 41633313 | PubTator, text mining | PubMed |
| Mendelian randomization analysis of the causal relationship between low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and androgenic alopecia. | Medicine (Baltimore) | 2026 | 41578511 | PubTator, text mining | PubMed |
| Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis. | Sci Rep | 2026 | 41559364 | PubTator, text mining | PubMed |
| Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia. | Schizophr Res | 2026 | 41544406 | PubTator, text mining | PubMed |
| A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer. | Ther Adv Med Oncol | 2025 | 41437935 | PubTator, text mining | PubMed |
| Evaluating the significance of combining PD-L1 and TILs as biomarkers in non-small cell lung cancer patients treated with immunotherapy: a systematic review. | BJC Rep | 2025 | 40983669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/175/papers